We are live on ! Find out more
NVRO

NEVRO CORP.
NVRO

Delisted

NVRO was delisted on the 2nd of April, 2025.

Back to rankings

177 hedge funds and large institutions have $1.63B invested in NEVRO CORP. in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $1.52B → $1.63B (+$113M)

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

1% more funds holding

Funds holding: 176 → 177 (+1)

3% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 60

11% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $32.7M

Holders
177
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
58
Reduced
60
Closed
27
Calls
$29.1M
Puts
$32.7M
Net Calls
-$3.64M
Net Calls Change
-$3.33M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$150M
2
Millennium Management
Millennium Management
New York
+$13.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$10.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.28M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$8.18M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$33.8M
2
Franklin Resources
Franklin Resources
California
-$30.5M
3
Marshall Wace
Marshall Wace
United Kingdom
-$22.8M
4
Victory Capital Management
Victory Capital Management
Texas
-$20.8M
5
RG
Redmile Group
California
-$17.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$4.23M +$246K +5,306 +6%
Jane Street
52
Jane Street
New York
$4.02M +$2.84M +61,262 +245%
Swiss National Bank
53
Swiss National Bank
Switzerland
$3.7M +$41.8K +900 +1%
SCM
54
Soleus Capital Management
Connecticut
$3.35M +$3.34M +72,000 New
CSS
55
Cubist Systematic Strategies
Connecticut
$3.16M +$3.06K +66 +0.1%
HM
56
HealthCor Management
New York
$3.15M +$3.14M +67,600 New
Legal & General Group
57
Legal & General Group
United Kingdom
$3.15M -$132K -2,853 -4%
Holocene Advisors
58
Holocene Advisors
New York
$3.03M -$1.16M -25,057 -28%
ACM
59
Altium Capital Management
New York
$2.98M -$1.16M -25,000 -28%
Nomura Holdings
60
Nomura Holdings
Japan
$2.6M +$662K +14,256 +35%
BA
61
Bridgewater Associates
Connecticut
$2.56M +$4.87K +105 +0.2%
ECM
62
ExodusPoint Capital Management
New York
$2.52M -$71.1K -1,531 -3%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
63
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$2.47M +$2.46M +53,000 New
CCM
64
Cinctive Capital Management
New York
$2.28M +$882K +19,012 +63%
E
65
Ergoteles
New York
$2.28M +$1.88M +40,491 +483%
Group One Trading
66
Group One Trading
Illinois
$2.15M +$2.14M +46,159 New
AllianceBernstein
67
AllianceBernstein
Tennessee
$2.11M – – –
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$2.09M +$155K +3,335 +8%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$1.99M -$36.6K -789 -2%
Envestnet Asset Management
70
Envestnet Asset Management
Illinois
$1.93M -$499K -10,759 -21%
Russell Investments Group
71
Russell Investments Group
United Kingdom
$1.69M -$312K -6,732 -16%
AG
72
Algert Global
California
$1.66M +$965K +20,789 +140%
TD Asset Management
73
TD Asset Management
Ontario, Canada
$1.65M – – –
SFI
74
Susquehanna Fundamental Investments
Pennsylvania
$1.64M +$1.63M +35,226 New
UBS AM
75
UBS AM
Illinois
$1.62M -$405K -8,727 -20%
1 2
3
4 5

NVRO Hedge Fund Activity: Q3 2022 in Review

177 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2022, worth a combined $1.63B — up 7.5% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NVRO positions and 27 closed out — a net gain of 1 holder — while 58 added to existing stakes and 60 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $150M. The largest seller was T. Rowe Price Associates, cutting an estimated $33.8M.

  • 177 institutional investors held NEVRO CORP. (NVRO) as of Q3 2022, up from 176 in Q2 2022.
  • Funds reported $1.63B of NEVRO CORP. stock for Q3 2022, up 7.5% quarter-over-quarter.
  • 28 funds opened new NEVRO CORP. positions in Q3 2022 and 27 closed out, a net change of +1 holder.
  • The largest NEVRO CORP. buyer in Q3 2022 was Fidelity Investments, an estimated $150M added.
  • The largest NEVRO CORP. seller in Q3 2022 was T. Rowe Price Associates, an estimated $33.8M sold.

Based on aggregated 13F filings for Q3 2022.